Concepts (215)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Bile Ducts, Intrahepatic | 5 | 2014 | 304 | 1.230 |
Why?
|
Liver Neoplasms | 20 | 2013 | 4362 | 1.220 |
Why?
|
Cholangiocarcinoma | 6 | 2014 | 561 | 1.040 |
Why?
|
Bile Duct Neoplasms | 5 | 2014 | 614 | 0.910 |
Why?
|
Hepatectomy | 10 | 2014 | 588 | 0.880 |
Why?
|
Students, Medical | 4 | 2014 | 1964 | 0.670 |
Why?
|
Problem-Based Learning | 2 | 2014 | 360 | 0.660 |
Why?
|
Pancreaticoduodenectomy | 5 | 2013 | 515 | 0.610 |
Why?
|
Carcinoma, Hepatocellular | 7 | 2013 | 2333 | 0.540 |
Why?
|
Education, Medical, Undergraduate | 3 | 2014 | 1085 | 0.460 |
Why?
|
Pakistan | 5 | 2014 | 299 | 0.460 |
Why?
|
Length of Stay | 10 | 2024 | 6498 | 0.430 |
Why?
|
Nomograms | 1 | 2014 | 236 | 0.400 |
Why?
|
Stethoscopes | 1 | 2012 | 30 | 0.400 |
Why?
|
Digestive System Surgical Procedures | 3 | 2015 | 583 | 0.390 |
Why?
|
Cadmium | 1 | 2013 | 217 | 0.390 |
Why?
|
Gallbladder Neoplasms | 1 | 2013 | 190 | 0.380 |
Why?
|
Workload | 2 | 2013 | 849 | 0.360 |
Why?
|
Cross-Cultural Comparison | 1 | 2014 | 638 | 0.360 |
Why?
|
Fatty Liver | 2 | 2013 | 809 | 0.340 |
Why?
|
Hepatitis C Antibodies | 1 | 2010 | 151 | 0.330 |
Why?
|
Attitude | 1 | 2014 | 771 | 0.320 |
Why?
|
Adenocarcinoma | 4 | 2013 | 6395 | 0.310 |
Why?
|
Hospital Mortality | 10 | 2024 | 5349 | 0.300 |
Why?
|
Syphilis | 1 | 2010 | 243 | 0.290 |
Why?
|
Learning | 2 | 2014 | 1759 | 0.280 |
Why?
|
SEER Program | 6 | 2013 | 1444 | 0.280 |
Why?
|
Embolization, Therapeutic | 2 | 2013 | 1402 | 0.270 |
Why?
|
Liver | 4 | 2015 | 7577 | 0.250 |
Why?
|
Patient Readmission | 4 | 2013 | 3288 | 0.250 |
Why?
|
Anemia, Sickle Cell | 1 | 2013 | 1065 | 0.240 |
Why?
|
Liver Diseases | 1 | 2013 | 1305 | 0.230 |
Why?
|
Motivation | 1 | 2014 | 2020 | 0.220 |
Why?
|
Referral and Consultation | 2 | 2013 | 3620 | 0.220 |
Why?
|
Colectomy | 3 | 2014 | 696 | 0.220 |
Why?
|
Hepacivirus | 1 | 2010 | 1344 | 0.200 |
Why?
|
Anesthesia | 1 | 2013 | 1596 | 0.200 |
Why?
|
Postoperative Complications | 8 | 2015 | 15832 | 0.200 |
Why?
|
Health Behavior | 1 | 2014 | 2650 | 0.200 |
Why?
|
Survival Rate | 8 | 2013 | 12840 | 0.200 |
Why?
|
Chemoembolization, Therapeutic | 2 | 2013 | 128 | 0.190 |
Why?
|
Colorectal Neoplasms | 5 | 2013 | 6974 | 0.190 |
Why?
|
Pancreatic Neoplasms | 3 | 2013 | 5446 | 0.190 |
Why?
|
Aged, 80 and over | 18 | 2014 | 59629 | 0.180 |
Why?
|
Male | 41 | 2024 | 364719 | 0.170 |
Why?
|
Comorbidity | 2 | 2013 | 10590 | 0.170 |
Why?
|
Hepatitis C | 1 | 2010 | 1595 | 0.160 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2014 | 4055 | 0.160 |
Why?
|
Hospital Costs | 1 | 2024 | 957 | 0.150 |
Why?
|
Pancreatectomy | 2 | 2013 | 825 | 0.150 |
Why?
|
United States | 17 | 2024 | 73039 | 0.150 |
Why?
|
Female | 38 | 2024 | 397192 | 0.150 |
Why?
|
Environmental Exposure | 1 | 2013 | 4543 | 0.150 |
Why?
|
Age Distribution | 3 | 2014 | 2873 | 0.140 |
Why?
|
Aged | 29 | 2015 | 171504 | 0.140 |
Why?
|
Smoking | 1 | 2014 | 9092 | 0.140 |
Why?
|
Middle Aged | 27 | 2024 | 223492 | 0.130 |
Why?
|
Maryland | 2 | 2013 | 278 | 0.130 |
Why?
|
Databases, Factual | 3 | 2024 | 8080 | 0.130 |
Why?
|
Psoas Muscles | 2 | 2013 | 66 | 0.120 |
Why?
|
Risk Assessment | 5 | 2024 | 24315 | 0.120 |
Why?
|
Combined Modality Therapy | 4 | 2014 | 8542 | 0.120 |
Why?
|
Humans | 43 | 2024 | 768166 | 0.120 |
Why?
|
Healthcare Disparities | 2 | 2024 | 3415 | 0.120 |
Why?
|
Retrospective Studies | 16 | 2024 | 81762 | 0.110 |
Why?
|
Physicians | 1 | 2012 | 4598 | 0.110 |
Why?
|
Italy | 2 | 2013 | 856 | 0.110 |
Why?
|
Kaplan-Meier Estimate | 6 | 2013 | 6526 | 0.110 |
Why?
|
Injections, Intra-Arterial | 1 | 2013 | 181 | 0.110 |
Why?
|
Infusions, Intra-Arterial | 1 | 2013 | 220 | 0.110 |
Why?
|
Tomography, X-Ray Computed | 2 | 2013 | 20760 | 0.110 |
Why?
|
Fibromatosis, Abdominal | 1 | 2012 | 21 | 0.100 |
Why?
|
Time Factors | 7 | 2024 | 40218 | 0.100 |
Why?
|
Asia | 1 | 2014 | 629 | 0.100 |
Why?
|
Patient Admission | 2 | 2024 | 1365 | 0.100 |
Why?
|
Neoplasm Recurrence, Local | 5 | 2013 | 9419 | 0.100 |
Why?
|
Colonic Diseases | 1 | 2014 | 204 | 0.100 |
Why?
|
Young Adult | 12 | 2024 | 60066 | 0.100 |
Why?
|
Duodenal Neoplasms | 1 | 2012 | 114 | 0.100 |
Why?
|
Analgesia, Epidural | 1 | 2015 | 332 | 0.100 |
Why?
|
Risk Factors | 11 | 2024 | 74944 | 0.100 |
Why?
|
Neoplasm Staging | 4 | 2014 | 11244 | 0.100 |
Why?
|
Fibromatosis, Aggressive | 1 | 2012 | 125 | 0.090 |
Why?
|
Sex Distribution | 2 | 2014 | 2278 | 0.090 |
Why?
|
Pulmonary Embolism | 1 | 2024 | 2599 | 0.090 |
Why?
|
Hepatic Artery | 1 | 2012 | 232 | 0.090 |
Why?
|
Knowledge | 1 | 2012 | 178 | 0.090 |
Why?
|
Equipment Contamination | 1 | 2012 | 183 | 0.090 |
Why?
|
Syphilis Serodiagnosis | 1 | 2010 | 37 | 0.090 |
Why?
|
Chemotherapy, Adjuvant | 3 | 2014 | 3556 | 0.090 |
Why?
|
Sarcopenia | 2 | 2013 | 378 | 0.090 |
Why?
|
Biliary Tract Neoplasms | 1 | 2012 | 187 | 0.090 |
Why?
|
Disease-Free Survival | 4 | 2013 | 6847 | 0.090 |
Why?
|
Disinfection | 1 | 2012 | 207 | 0.090 |
Why?
|
Europe | 2 | 2014 | 3436 | 0.090 |
Why?
|
Self Efficacy | 1 | 2014 | 643 | 0.080 |
Why?
|
Curriculum | 2 | 2014 | 3782 | 0.080 |
Why?
|
Propensity Score | 2 | 2015 | 1969 | 0.080 |
Why?
|
Portal Vein | 1 | 2012 | 435 | 0.080 |
Why?
|
Medicare | 5 | 2013 | 6809 | 0.080 |
Why?
|
Videotape Recording | 1 | 2011 | 335 | 0.080 |
Why?
|
Dissection | 1 | 2011 | 299 | 0.080 |
Why?
|
Seroepidemiologic Studies | 1 | 2010 | 404 | 0.080 |
Why?
|
Cross-Sectional Studies | 4 | 2014 | 26379 | 0.080 |
Why?
|
Magnetic Resonance Imaging | 2 | 2013 | 36743 | 0.080 |
Why?
|
Anatomy | 1 | 2011 | 126 | 0.080 |
Why?
|
Follow-Up Studies | 4 | 2014 | 39348 | 0.080 |
Why?
|
Necrosis | 1 | 2013 | 1616 | 0.080 |
Why?
|
Hospitals, Teaching | 1 | 2013 | 1157 | 0.080 |
Why?
|
Logistic Models | 5 | 2013 | 13290 | 0.080 |
Why?
|
Educational Measurement | 2 | 2012 | 1260 | 0.080 |
Why?
|
ras Proteins | 1 | 2013 | 1058 | 0.080 |
Why?
|
Pancreas | 1 | 2015 | 1700 | 0.080 |
Why?
|
Confidence Intervals | 1 | 2014 | 2923 | 0.080 |
Why?
|
Lymphatic Metastasis | 2 | 2013 | 2914 | 0.070 |
Why?
|
Rectum | 1 | 2013 | 900 | 0.070 |
Why?
|
Postoperative Period | 1 | 2013 | 1826 | 0.070 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2013 | 1791 | 0.070 |
Why?
|
Health Status Disparities | 2 | 2024 | 1885 | 0.070 |
Why?
|
Choice Behavior | 1 | 2013 | 848 | 0.070 |
Why?
|
Cohort Studies | 7 | 2013 | 41754 | 0.070 |
Why?
|
Hemangioma | 1 | 2012 | 727 | 0.070 |
Why?
|
Robotics | 1 | 2014 | 812 | 0.070 |
Why?
|
Cysts | 1 | 2012 | 685 | 0.070 |
Why?
|
Adult | 14 | 2024 | 223646 | 0.070 |
Why?
|
Prognosis | 5 | 2013 | 30010 | 0.070 |
Why?
|
Adolescent | 10 | 2024 | 89169 | 0.070 |
Why?
|
Gastrointestinal Stromal Tumors | 1 | 2012 | 617 | 0.070 |
Why?
|
Health Care Surveys | 1 | 2013 | 2434 | 0.070 |
Why?
|
Health Services Research | 1 | 2014 | 1815 | 0.070 |
Why?
|
Spinal Cord Injuries | 1 | 2014 | 928 | 0.060 |
Why?
|
Perioperative Care | 1 | 2013 | 1043 | 0.060 |
Why?
|
Early Diagnosis | 1 | 2010 | 1194 | 0.060 |
Why?
|
Research | 1 | 2014 | 1979 | 0.060 |
Why?
|
Infection Control | 1 | 2012 | 985 | 0.060 |
Why?
|
Neoplasm Invasiveness | 1 | 2013 | 3620 | 0.060 |
Why?
|
Cross Infection | 1 | 2013 | 1426 | 0.060 |
Why?
|
Survival Analysis | 2 | 2014 | 10101 | 0.060 |
Why?
|
Program Evaluation | 1 | 2012 | 2507 | 0.060 |
Why?
|
Cost of Illness | 1 | 2014 | 1951 | 0.060 |
Why?
|
Rectal Neoplasms | 1 | 2013 | 1183 | 0.060 |
Why?
|
Odds Ratio | 2 | 2013 | 9669 | 0.060 |
Why?
|
Urban Health Services | 1 | 2024 | 177 | 0.060 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2013 | 2059 | 0.050 |
Why?
|
Survivors | 1 | 2014 | 2381 | 0.050 |
Why?
|
Rural Health | 1 | 2024 | 302 | 0.050 |
Why?
|
Registries | 3 | 2014 | 8375 | 0.050 |
Why?
|
Hospitals, Urban | 1 | 2024 | 497 | 0.050 |
Why?
|
Academic Medical Centers | 1 | 2013 | 2784 | 0.050 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 3814 | 0.050 |
Why?
|
Cause of Death | 1 | 2013 | 3721 | 0.050 |
Why?
|
Urban Health | 1 | 2024 | 535 | 0.050 |
Why?
|
Laparoscopy | 1 | 2014 | 2041 | 0.050 |
Why?
|
Surgical Procedures, Operative | 1 | 2013 | 1932 | 0.050 |
Why?
|
Adenoma | 1 | 2012 | 2159 | 0.050 |
Why?
|
Recurrence | 1 | 2014 | 8509 | 0.050 |
Why?
|
Proto-Oncogene Proteins | 1 | 2013 | 4528 | 0.050 |
Why?
|
Rural Health Services | 1 | 2024 | 394 | 0.050 |
Why?
|
Colonic Neoplasms | 1 | 2013 | 2541 | 0.050 |
Why?
|
Patient Discharge | 1 | 2013 | 3479 | 0.040 |
Why?
|
Prevalence | 2 | 2014 | 15869 | 0.040 |
Why?
|
Attitude of Health Personnel | 1 | 2013 | 3929 | 0.040 |
Why?
|
Software | 1 | 2013 | 4478 | 0.040 |
Why?
|
Multivariate Analysis | 4 | 2013 | 12077 | 0.040 |
Why?
|
Treatment Outcome | 9 | 2024 | 65371 | 0.040 |
Why?
|
Genotype | 1 | 2013 | 13045 | 0.040 |
Why?
|
Incidence | 2 | 2014 | 21538 | 0.040 |
Why?
|
Proportional Hazards Models | 4 | 2013 | 12543 | 0.040 |
Why?
|
Carcinoma, Renal Cell | 1 | 2012 | 3187 | 0.030 |
Why?
|
Positron-Emission Tomography | 1 | 2013 | 6669 | 0.030 |
Why?
|
Chi-Square Distribution | 2 | 2012 | 3436 | 0.030 |
Why?
|
Gastrointestinal Hemorrhage | 2 | 2014 | 1126 | 0.030 |
Why?
|
Respiratory Insufficiency | 2 | 2015 | 1240 | 0.030 |
Why?
|
Kidney Neoplasms | 1 | 2012 | 4282 | 0.030 |
Why?
|
Infant | 2 | 2013 | 36535 | 0.030 |
Why?
|
Child, Preschool | 2 | 2013 | 42669 | 0.030 |
Why?
|
Age Factors | 2 | 2024 | 18412 | 0.030 |
Why?
|
New South Wales | 1 | 2012 | 69 | 0.030 |
Why?
|
Mitotic Index | 1 | 2012 | 162 | 0.030 |
Why?
|
Poisson Distribution | 1 | 2013 | 506 | 0.020 |
Why?
|
Baltimore | 1 | 2012 | 233 | 0.020 |
Why?
|
Carcinoembryonic Antigen | 1 | 2012 | 338 | 0.020 |
Why?
|
Abdominal Neoplasms | 1 | 2012 | 287 | 0.020 |
Why?
|
Sex Factors | 1 | 2024 | 10632 | 0.020 |
Why?
|
Quality of Life | 1 | 2012 | 13490 | 0.020 |
Why?
|
Pelvic Neoplasms | 1 | 2012 | 250 | 0.020 |
Why?
|
Radiology, Interventional | 1 | 2013 | 483 | 0.020 |
Why?
|
Mutation | 1 | 2013 | 30238 | 0.020 |
Why?
|
Intestinal Obstruction | 1 | 2012 | 433 | 0.020 |
Why?
|
Child | 2 | 2013 | 80917 | 0.020 |
Why?
|
Salvage Therapy | 1 | 2014 | 1273 | 0.020 |
Why?
|
Canada | 1 | 2012 | 2130 | 0.020 |
Why?
|
Gastroenterology | 1 | 2013 | 593 | 0.020 |
Why?
|
Cadaver | 1 | 2011 | 1363 | 0.020 |
Why?
|
China | 1 | 2012 | 2395 | 0.020 |
Why?
|
Abdominal Pain | 1 | 2012 | 1070 | 0.020 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2013 | 1767 | 0.020 |
Why?
|
Pain, Postoperative | 1 | 2015 | 1765 | 0.010 |
Why?
|
Regression Analysis | 1 | 2014 | 6340 | 0.010 |
Why?
|
Perception | 1 | 2011 | 1209 | 0.010 |
Why?
|
Pneumonia | 1 | 2015 | 2163 | 0.010 |
Why?
|
Preoperative Care | 1 | 2012 | 2258 | 0.010 |
Why?
|
Quality Indicators, Health Care | 1 | 2012 | 1805 | 0.010 |
Why?
|
General Surgery | 1 | 2013 | 1720 | 0.010 |
Why?
|
Acute Kidney Injury | 1 | 2014 | 1942 | 0.010 |
Why?
|
Medical Oncology | 1 | 2013 | 2346 | 0.010 |
Why?
|
Sepsis | 1 | 2015 | 2608 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2012 | 5315 | 0.010 |
Why?
|
Neoadjuvant Therapy | 1 | 2012 | 2907 | 0.010 |
Why?
|
Patient Satisfaction | 1 | 2012 | 3488 | 0.010 |
Why?
|
Health Personnel | 1 | 2013 | 3385 | 0.010 |
Why?
|
Body Mass Index | 1 | 2013 | 13053 | 0.010 |
Why?
|
Hospitalization | 1 | 2014 | 10840 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2013 | 13676 | 0.010 |
Why?
|
Lung Neoplasms | 1 | 2012 | 13586 | 0.000 |
Why?
|
Concepts
(215)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(2)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_